Patients with post-stroke hemiplegia in the chronic phase.
Conditions
Interventions
Treatment with penetrating needles
Treatment with no-touch placebo needles (no stimulation with the needle tip that does not reach the skin)
Sponsors
Tokyo Ariake University of Medical and Health Science
Y`s,Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with chronic stroke hemiplegia (between 6 months and 4 years after onset) 2) Patients who have sensory impairment and can walk out with or without the use of a walking aid.
Exclusion criteria
Exclusion criteria: 1) Acute stroke patients (within 6 months after onset) or chronic stroke patients more than 4 years post-onset. 2) Diseases that are contraindications to rehabilitation, such as cardiac disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Muscle activity in spastic muscles (soleus) by superficial electromyography (sEMG) 2) Change of movement of the lower limbs in life (Visual Analogue Scale :VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Modified ashworth scale 2) Fugl-Meyer assessment 3) Stroke-specific quality of life scale 4) Ease of taking a step on VAS 5) Practitioner's and patient's guess at the needle authenticity and their confidence in their guess on a VAS | — |
Countries
Japan
Contacts
Public ContactNoriyuki Ueno
Y`s,Inc. Corporate services department
Outcome results
None listed